- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
27 result(s) found for: Nerve Conduction Velocity.
Displaying page 1 of 2.
EudraCT Number: 2014-000348-14 | Sponsor Protocol Number: NSTATIN | Start Date*: 2014-03-05 |
Sponsor Name:Odense University Hospital, Department of Neurology | ||
Full Title: Statin-treatment and peripheral neuropathy - a randomized clinical trial | ||
Medical condition: Patients with cerebral infarction or transient ischemic attack. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-002843-18 | Sponsor Protocol Number: AS3201-G000-291 | Start Date*: 2009-09-21 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-center, Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimo... | |||||||||||||
Medical condition: Diabetic Sensorimotor Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) EE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000182-31 | Sponsor Protocol Number: CHDR1438 | Start Date*: 2015-02-11 |
Sponsor Name:CHDR | ||
Full Title: A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction in patients with multiple sclerosis (MS) and a unilateral ... | ||
Medical condition: Multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002632-90 | Sponsor Protocol Number: OF_NEIR_CT1 | Start Date*: 2020-11-09 |
Sponsor Name:"Olainfarm" AS | ||
Full Title: A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathy | ||
Medical condition: Lumbosacral radiculopathy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: PL (Completed) CZ (Completed) LV (Completed) BG (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001246-17 | Sponsor Protocol Number: CBX129801-DN-201 | Start Date*: 2013-05-28 |
Sponsor Name:Cebix Incorporated | ||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of CBX129801 (Ersatta™), Long-Acting Synthetic C-Peptide, in Type 1 Diabetes Mellitus Subjects wit... | ||
Medical condition: Mild to moderate diabetic peripheral neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001404-40 | Sponsor Protocol Number: KF9906/02 | Start Date*: 2005-09-02 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Cross-over multiple dose study assessing the analgesic efficacy and safety of oral GRT9906 PR compared to active comparator and placebo in subjects with painful polyneuropathy of mixed origin | |||||||||||||
Medical condition: Polyneuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003054-16 | Sponsor Protocol Number: DDZ-BOND-2017 | Start Date*: 2018-07-27 | |||||||||||
Sponsor Name:Wörwag Pharma GmbH & co. KG | |||||||||||||
Full Title: Randomized double-blind, placebo-controlled parallel group study over 12 months to assess the effects of treatment with benfotiamine on morphometric, neurophysiological, and clinical measures in ty... | |||||||||||||
Medical condition: diabetic polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003272-23 | Sponsor Protocol Number: NUBE | Start Date*: 2014-10-24 | |||||||||||
Sponsor Name:Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge | |||||||||||||
Full Title: Prospective Pilot Study of the treatment of compression of median nerve neuropathy with Nucleo CMP Forte®. | |||||||||||||
Medical condition: Carpal Tunnel Syndrome (CTS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004921-33 | Sponsor Protocol Number: R475-OA-1758 | Start Date*: 2018-11-09 | ||||||||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain Due to Osteoarthritis of the Hip or Knee | ||||||||||||||||||
Medical condition: Pain due to osteoarthritis of the hip or knee | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002289-62 | Sponsor Protocol Number: ST200-SSMA-14-001 | Start Date*: 2014-09-11 | |||||||||||
Sponsor Name:SIGMA-TAU, Industrie Farmaceutiche Riunite S.p.A. | |||||||||||||
Full Title: Electroneurographic and clinical evaluation in patients with mild / moderate Carpal Tunnel Syndrome , following conservative pharmacological treatment with Nicetile®. | |||||||||||||
Medical condition: Carpal Tunnel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005341-11 | Sponsor Protocol Number: rhASA-01 | Start Date*: 2006-12-28 | |||||||||||
Sponsor Name:Shire Pharmaceuticals Ireland Limited | |||||||||||||
Full Title: A single center, open-label, non-randomized, uncontrolled, multiple-dose, dose escalation study of the safety, pharmacokinetics and efficacy of Metazym (recombinant human arylsulfatase A or rhASA) ... | |||||||||||||
Medical condition: Late infantile metachromatic leukodystrophy (MLD) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002810-15 | Sponsor Protocol Number: CHUB-Neuro-ENMG-MS | Start Date*: 2021-06-25 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Peripheral neuropathy as potential side effect in patients with multiple sclerosis treated with teriflunomide. | |||||||||||||
Medical condition: Multiple sclerosis, treated with teriflunomide | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005717-80 | Sponsor Protocol Number: FAB117-CT-01 | Start Date*: 2016-05-29 | ||||||||||||||||
Sponsor Name:Ferrer Internacional S.A | ||||||||||||||||||
Full Title: Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipos... | ||||||||||||||||||
Medical condition: Patients with acute traumatic spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002378-19 | Sponsor Protocol Number: CLN-PXT3003-02 | Start Date*: 2015-08-27 | |||||||||||
Sponsor Name:PHARNEXT | |||||||||||||
Full Title: International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-T... | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease - Type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Suspended by CA) ES (Completed) BE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006113-34 | Sponsor Protocol Number: XAMNPIOAP2011 | Start Date*: 2013-10-24 |
Sponsor Name:AURORA PUJOL ONOFRE | ||
Full Title: Effect of pioglitazone administred to patients with Adrenomyeloneuropathy: A phase II, Singlearm, Monocentric Trial. | ||
Medical condition: X-linked adrenoleukodystrophy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005024-40 | Sponsor Protocol Number: NPP100023 | Start Date*: 2005-04-06 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LAMOTRIGINE 200-400MG/DAY COMPARED WITH PLACEBO IN SUBJECTS WITH PAINFUL DIA... | ||
Medical condition: Painful Diabetic Neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) LV (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-006291-39 | Sponsor Protocol Number: 215ON201 | Start Date*: 2012-10-15 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With First Episode of Acute Optic Neur... | |||||||||||||
Medical condition: Acute Optic Neuritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) BE (Completed) DE (Completed) CZ (Completed) GB (Completed) HU (Completed) ES (Completed) IT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003561-17 | Sponsor Protocol Number: 750CNP01 | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:Toray Industries, Inc. | |||||||||||||
Full Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TRK-750 in Colorectal Cancer Patients with Chemotherapy-induced Peripheral Neuropathy Following Oxaliplatin-con... | |||||||||||||
Medical condition: Chemotherapy-induced peripheral neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) ES (Prematurely Ended) DK (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000004-13 | Sponsor Protocol Number: ST200-DM-04-005 | Start Date*: 2005-09-16 | |||||||||||
Sponsor Name:Sigma-Tau i.f.r. S.p.A. | |||||||||||||
Full Title: EVALUATION OF ACETYL -L-CARNITINE (ST 200) TO REDUCE INTENSITY OF TAXANES- OR PLATINUM-INDUCED SENSORY NEUROPATHY | |||||||||||||
Medical condition: Peripheral neurophaty in cancer patients previously treated with taxanes- or platinum-based chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004375-12 | Sponsor Protocol Number: TODINELI | Start Date*: 2014-02-13 | |||||||||||||||||||||
Sponsor Name:Center of Mech-Sense | |||||||||||||||||||||||
Full Title: TODINELI Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of the neuroprotective effect of Liraglutide for treatment of diabetic neuropathy | |||||||||||||||||||||||
Medical condition: TODINELI Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of the neuroprotective effect of Liraglutide for treatment of diabetic neuropathy i... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.